Key research themes
1. How can surfactant replacement therapy be optimized for neonatal and adult respiratory distress syndromes?
This research area investigates the biological basis, clinical application, and future directions of surfactant replacement therapy (SRT) focusing on endogenous surfactant physiology, different exogenous surfactant types (animal-derived, synthetic), administration techniques, and ventilation strategies. Understanding surfactant composition, protein roles, kinetics, and homeostasis is critical to improve therapy in neonatal respiratory distress syndrome (RDS) and explore applications in adult acute respiratory distress syndrome (ARDS).
2. What are the biophysical mechanisms underlying pulmonary surfactant function and how do surfactant components contribute to thin film stability?
This theme explores the molecular composition, surface-active properties, interactions of lipids and surfactant proteins, and rheological behaviors that enable surfactant to reduce alveolar surface tension and maintain lung compliance. It includes studies analyzing pure components like DPPC, commercial surfactant replacements, and synthetic constructs. Understanding these biophysical phenomena is crucial for designing more effective natural and synthetic surfactants and improving stability, spreading, and resistance to inactivation in both neonatal and adult lungs.
3. How does pulmonary surfactant dysfunction contribute to respiratory diseases beyond neonatal RDS, such as COVID-19 ARDS, cystic fibrosis, bronchiolitis, and lung injury, and what therapeutic insights emerge?
This research area investigates alterations/dysfunction in surfactant quantity, composition, and biophysical function across various respiratory diseases including COVID-19 ARDS, pediatric cystic fibrosis, bronchiolitis, drowning-related lung injury, and chemically induced lung fibrosis. It also examines the pathological consequences of surfactant deficiency/dysfunction, molecular mechanisms such as cholesterol and oxidation effects, and explores potential therapies including surfactant replacement, polymer additives, and drug modulation strategies. Improved characterization enables tailored interventions to restore surfactant function and mitigate respiratory failure.